Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Clinical Trials
33%
Breast Cancer
33%
Synergistic Effect
33%
Overexpression
33%
Targeted Therapy
33%
Improved Patient Outcomes
33%
Metastatic Breast Cancer
33%
Poor Outcome
33%
Early Breast Cancer
33%
Resistance Development
33%
Anti-human Epidermal Growth Factor Receptor 2
33%
Medicine and Dentistry
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Translating (Language)
100%
Breast Cancer
50%
Clinical Trial
25%
Targeted Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Breast Cancer
50%
Clinical Trial
25%
Biochemistry, Genetics and Molecular Biology
Translating (Language)
100%
Epidermal Growth Factor Receptor
100%
Clinical Trial
25%
Neuroscience
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Immunology and Microbiology